Business Description
Genfit S.A. is a French biopharmaceutical company focused on developing treatments and diagnostic tools for liver and metabolic diseases. Its pipeline includes several drug candidates at various stages of clinical testing, targeting conditions such as primary biliary cholangitis, liver failure, and rare metabolic disorders. The company also develops blood-based diagnostic tests for liver disease and works with partners including Labcorp and Genoscience Pharma to bring its products to market. Founded in 1999, Genfit is headquartered in Loos, France.
